Bel Power Solutions Announces 1000 W ABE1000 Series and MBE1000 Series AC-DC Enclosed Power Supplies
High-Power Density Solutions for Industrial and Medical Applications
Santa Clara, CA [September 19, 2019] Bel Power Solutions, a Bel group company (NASDAQ: BELFA and BELFB) and premier global manufacturer of power management devices, today announced the ABE1000 Series and MBE1000 Series of enclosed power supplies, which are ideal for industrial (ABE Series) and medical (MBE Series) applications and available in a variety of single output voltages.
The ABE1000 Series features a wide universal AC input range of 85-264 VAC, offering up to 1000 W of output power with an integrated fan, in a compact footprint (5.0 x 9.51 x 1.61" (127.0 x 241.5 x 41 mm)) and with a variety of single output voltages. The high efficiency and high-power density of the ABE1000 Series ensures minimal power loss in end-use equipment, thereby facilitating higher reliability, easier thermal management and meets regulatory approvals for environmentally-friendly end products. These power supplies are ideal for industrial and medical equipment.
The MBE1000 Series is designed and approved to the latest Medical standards (EN/IEC 60601-1), providing 2 x MOPP isolation for Class I & Class II applications. These medical power supplies are ideal for diagnostic, drug pump, dialysis, home health care, monitoring and imaging, as well as therapy and surgical devices.
Both the ABE1000 Series and MBE1000 Series are available from DigiKey (ABE1000 / MBE1000), Mouser (ABE1000 / MBE1000), Arrow, Allied Electronics and Master Electronics (ABE1000 / MBE1000). For more detailed information on the ABE1000 Series, visit the part page here or download the datasheet. For more detailed information on the MBE1000 Series, visit the part page here or download the datasheet.
For technical inquiries, send an eMail to Tech.Support@psbel.com, call +1 866-513-2839 for North America, +49 6172 95520 for EMEA, +1 86 755 29885888 for Asia Pacific or visit belfuse.com/power-solutions.
Bel (www.belfuse.com) designs, manufactures and markets a broad array of products that power, protect and connect electronic circuits. These products are primarily used in the networking, telecommunications, computing, military, aerospace, transportation and broadcasting industries. Bel’s product groups include Magnetic Solutions (integrated connector modules, power transformers, power inductors and discrete components), Power Solutions and Protection (front-end, board-mount and industrial power products, module products and circuit protection), and Connectivity Solutions (expanded beam fiber optic, copper-based, RF and RJ connectors and cable assemblies). The Company operates facilities around the world.
Except for historical information contained in this press release, the matters discussed in this press release are forward looking statements as described under the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Actual results could differ materially from Bel’s projections. Among the factors that could cause actual results to differ materially from such statements are: the market concerns facing our customers; the continuing viability of sectors that rely on our products; the effects of business and economic conditions; difficulties associated with integrating recently acquired companies; capacity and supply constraints or difficulties; product development, commercialization
or technological difficulties; the regulatory and trade environment; risks associated with foreign currencies; uncertainties associated with legal proceedings; the market’s acceptance of the Company’s new products and competitive responses to those new products; our ongoing evaluation of the consequences of the U.S. Tax Cuts and Jobs Act; the impact of changes to U.S. trade and tariff policies; and the risk factors detailed from time to time in the Company’s SEC reports. In light of the risks and uncertainties, there can be no assurance that any forward-looking statement will in fact prove to be correct. We undertake no obligation to update or revise any forward-looking statements.